These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17117054)

  • 21. Use of low-dose low molecular weight heparin in hemodialysis.
    Lai KN; Wang AY; Ho K; Szeto CC; Li M; Wong LK; Yu AW
    Am J Kidney Dis; 1996 Nov; 28(5):721-6. PubMed ID: 9158210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer?
    Ward RA
    Semin Dial; 2011; 24(1):65-71. PubMed ID: 21323999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of two dialysers (AN69ST vs. FX100) for heparin-free dialysis in patients with oral anticoagulation.
    Kodras K; Benesch T; Neumann I; Haas M
    Blood Purif; 2008; 26(3):226-30. PubMed ID: 18305385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Residual blood loss in single use dialyzers: effect of different membranes and flux.
    Kalocheretis P; Vlamis I; Belesi C; Makriniotou I; Zerbala S; Savidou E; Zorbas S; Arvanitis N; Iatrou C
    Int J Artif Organs; 2006 Mar; 29(3):286-92. PubMed ID: 16685672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trial.
    Rossignol P; Dorval M; Fay R; Ros JF; Loughraieb N; Moureau F; Laville M
    Trials; 2013 Jun; 14():163. PubMed ID: 23725299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adequacy of fragmin as a single bolus dose with reused dialyzers.
    Kerr PG; Mattingly S; Lo A; Atkins RC
    Artif Organs; 1994 Jun; 18(6):416-9. PubMed ID: 8060249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical study to assess the effect of heparin in dialyzer rinsing solutions.
    Opatrný K; Bouda M; Kohoutková L; Vít L; Sefrna F
    Int J Artif Organs; 1997 Feb; 20(2):112-8. PubMed ID: 9093891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving hollow fiber dialyzer efficiency with a recirculating dialysate system II: comparison against two-chamber dialysis systems.
    Prado M; Roa LM; Palma A; Milán JA
    Ann Biomed Eng; 2005 Nov; 33(11):1595-606. PubMed ID: 16341926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Polaschegg HD
    Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimization of heparin anticoagulation for hemodialysis.
    Davenport A
    Hemodial Int; 2011 Oct; 15 Suppl 1():S43-8. PubMed ID: 22093600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of heparin modeling on delivered hemodialysis therapy.
    Wei SS; Ellis PW; Magnusson MO; Paganini EP
    Am J Kidney Dis; 1994 Mar; 23(3):389-93. PubMed ID: 8128940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.
    Krane V; Krieter DH; Olschewski M; März W; Mann JF; Ritz E; Wanner C
    Am J Kidney Dis; 2007 Feb; 49(2):267-75. PubMed ID: 17261429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of the effectiveness of hemodialysis using only heparin or prostacyclin with heparin].
    Kuźniewski M; Sułowicz W
    Przegl Lek; 1990; 47(3):328-31. PubMed ID: 2236625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.
    Laville M; Dorval M; Fort Ros J; Fay R; Cridlig J; Nortier JL; Juillard L; Dębska-Ślizień A; Fernández Lorente L; Thibaudin D; Franssen C; Schulz M; Moureau F; Loughraieb N; Rossignol P
    Kidney Int; 2014 Dec; 86(6):1260-7. PubMed ID: 25007166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.
    Kiaii M; Djurdjev O; Farah M; Levin A; Jung B; MacRae J
    JAMA; 2011 Oct; 306(15):1679-87. PubMed ID: 22009100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-free hemodialysis with Cuprophan hollow fiber dialyzers by a frequent saline flush, high blood flow technique.
    Agresti J; Conroy JD; Olshan A; Conroy JF; Schwartz A; Brodsky I; Krevolin L; Chinitz J
    Trans Am Soc Artif Intern Organs; 1985; 31():590-4. PubMed ID: 3837514
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.
    Vanommeslaeghe F; De Somer F; Josipovic I; Boone M; Dhondt A; Van Biesen W; Eloot S
    Artif Organs; 2019 Aug; 43(8):756-763. PubMed ID: 30820962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History of hemodialyzers' designs.
    Twardowski ZJ
    Hemodial Int; 2008 Apr; 12(2):173-210. PubMed ID: 18394051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.